To identify the genetic determinants of colon tumorigenesis, 268 male mice from 33 inbred strains derived from different genealogies were treated with Azoxymethane (AOM) (10 mg/kg) once a week for six weeks to induce colon tumors. Tumors were localized exclusively within the distal colon in each of the strains examined. Inbred mouse strains exhibit a large variability in genetic susceptibility to AOM-induced colon tumorigenesis. The mean colon tumor multiplicity ranged from 0 to 38.6 (mean = 6.5 ± 8.6) and tumor volume ranged from 0 to 706.5 mm 3 (mean = 87.4 ± 181.9) at 24 weeks after the first dose of AOM. AOM-induced colon tumor phenotypes are highly heritable in inbred mice, and 68.8% and 71.3% of total phenotypic variation in colon tumor multiplicity and tumor volume, respectively, are attributable to straindependent genetic background. Using 97,854 SNPs, we performed a genome-wide association study (GWAS) of AOM-induced colon tumorigenesis and identified a novel susceptibility locus on chromosome 15 (rs32359607, P = 6.31 × 10 -6
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Abstract
To identify the genetic determinants of colon tumorigenesis, 268 male mice from 33 inbred strains derived from different genealogies were treated with Azoxymethane (AOM) (10 mg/kg) once a week for six weeks to induce colon tumors. Tumors were localized exclusively within the distal colon in each of the strains examined. Inbred mouse strains exhibit a large variability in genetic susceptibility to AOM-induced colon tumorigenesis. The mean colon tumor multiplicity ranged from 0 to 38.6 (mean = 6.5 ± 8.6) and tumor volume ranged from 0 to 706.5 mm 3 (mean = 87.4 ± 181.9) at 24 weeks after the first dose of AOM. AOM-induced colon tumor phenotypes are highly heritable in inbred mice, and 68.8% and 71.3% of total phenotypic variation in colon tumor multiplicity and tumor volume, respectively, are attributable to straindependent genetic background. Using 97,854 SNPs, we performed a genome-wide association study (GWAS) of AOM-induced colon tumorigenesis and identified a novel susceptibility locus on chromosome 15 (rs32359607, P = 6.31 × 10 -6 ). Subsequent fine mapping confirmed five (Scc3, Scc2, Scc12, Scc8 and Ccs1) of 16 linkage regions previously found to be associated with colon tumor susceptibility. These five loci were refined to less than 1-Mb genomic regions of interest. Major candidates in these loci are Sema5a, Fmn2, Grem2, Fap, Gsg1l, Xpo6, Rabep2, Eif3c, Unc5d and Gpr65. In particular, the refined Scc3 locus shows high concordance with the human GWAS locus that underlies Hereditary Mixed Polyposis Syndrome. These findings increase our understanding of the complex genetics of colon tumorigenesis, and provide important insights into the pathways of colorectal cancer development and might ultimately lead to more effective individually targeted cancer-prevention strategies.
Introduction
Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the United States. In 2010, there will be an estimated 50,000 deaths associated with this disease (1) .
Genetic factors play important roles in CRC development and account for ~ 35% of CRC risk (2) .
Highly penetrant germline mutations in APC, SMAD4, BMPR1A, MUTYH, STK11 and DNA mismatch repair genes are estimated to account for ~ 6% of all CRC cases (3) . In addition to these rare variants, much of CRC inherited susceptibility is likely attributable to multiple lowpenetrance common variants. Direct evidence for common variants for CRC is highlighted by recent genome-wide association studies (GWAS). These GWAS on CRC have identified 10 independent loci that confer risk of CRC, including those on chromosomes 8q24.21, 11q23, 18q21.1, 8q23.1 15q , 19q13.1, 20q12.3, 14q22.2, 16q22.1 and 10p14 (4) (5) (6) (7) (8) (9) (10) . However, risk associated with these common variants is modest and only a small proportion of CRC risk can be explained by currently identified loci. Other genetic factors underlying CRC remain unidentified and this strongly supports the continued search for novel CRC susceptibility genes.
Inbred strains of laboratory mice have been valuable in the identification of tumor susceptibility genes because they display a wide range of spontaneous and chemically induced tumor incidence. A number of linkage mapping studies using cross-breeding experiments were performed for chemically induced colon tumors in mice (11) (12) (13) (14) (15) (16) . As a result, 16 quantitative trait loci (QTLs) responsible for chemically induced colon tumors have been mapped on the mouse genome, implying a very complex picture of inherited susceptibility of colon tumorigenesis exists. However, a major obstacle of identifying QTL genes is the difficulty of resolving these chromosomal regions (10~20 cM) into sufficiently small intervals to make positional cloning possible. These colon tumor QTLs span a total of 178 cM that corresponds to 351 Mb, covering (17) . The use of dense SNP maps in laboratory inbred mice has proven successful in the refinement of previous QTL regions and the identification of new genetic determinants of complex traits (18, 19) .
Here, we carried out a genome-wide association study to map novel susceptibility loci and refine previous QTL regions for colon tumorigenesis in inbred mice. A total of 268 male mice from 33 inbred strains were treated with Azoxymethane (AOM), an organotropic colon carcinogen, to induce colon tumors. We identified a novel genetic susceptibility locus on mouse chromosome 15 and narrowed five of 16 previous linkage regions into less than 1-Mb genomic regions of interest in which candidate genes were identified.
Materials and Methods
Inbred mouse strains and SNP Data
Thirty-three inbred mouse strains were used in our colon cancer study. The chosen inbred 
Colon tumorigenesis assays
The inbred mouse strains were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were housed in plastic cages with hardwood bedding and dust covers, in a HEPA 
Genome-wide SNP Association Analysis
To correct for population structure and genetic relatedness among inbred strains, we used a recently developed method, efficient mixed model association (EMMA) approach, to assess association of colon tumor susceptibility with SNPs (21) . Specifically, the mixed model in the EMMA method can be represented by:
where y is an n × 1 vector of observed phenotypes (i.e., colon tumor multiplicity and volume), and X is an n × q matrix of fixed effects including mean, SNPs, and other covariate variables. β is a q × 1 vector representing coefficients of the fixed effects. Z is an n × t incidence matrix mapping each observed phenotype to one of t inbred strains. u is the random effect (i.e., strain effects) of the mixed model with Var(u) = An R package implementation of the EMMA method is publicly available (http://mouse.cs.ucla.edu/emma/). A two-sided p-value from the EMMA for each SNP was obtained for testing hypothesis of no association between the SNP and colon tumor phenotypes.
Prior to the statistical analysis, colon tumor multiplicity and volume were converted into normal data by Box-cox transformation.
Two hundred permutations were used to establish a genome-wide threshold (a global p value of 0.05) for declaring significant associations in the association analysis, which take into account linkage disequilibrium among SNPs on the genome (22) . Specifically, colon tumor 7 phenotypes were randomly reshuffled among subjects while fixing the genotypes. For each permutation, the EMMA approach described above was implemented, and the most significantlog 10 (P) was recorded. Sorting the maximum -log 10 (P) from large to small, the 5% quantile of the empirical distribution was taken as the genome-wide threshold (a global p value of 0.05 and 0.10). We also used the above simulation procedure to determine a region-wide threshold for each colon susceptibility locus from previous linkage studies. The only difference here is to perform association tests in that linkage region instead of the whole genome. Briefly, we first identified one LOD (logarithm of the odds) supporting interval for each of the previous linkage regions. Then we performed permutation analysis as described above in the identified one LOD supporting interval.
Detection of differential expression in colon tumor models and human colon cancer studies
Mouse cDNA array data were downloaded from the Gene Expression Omnibus database (GSE5261). We analyzed 14 tumor samples from the AOM-induced mouse colon model (23), 9 tumor samples from the Apc Min/+ mouse model (24) and 3 adult normal mouse colon. The expression data were normalized by Lowess intensity-dependent normalization as implemented in GeneSpring 7.2. Then, the samples were referenced to expression levels of normal control colon samples (25) . Two-sample t-tests were used to detect differential expression between tumor and control samples.
Human colon cancer microarray data were downloaded from the Gene Expression Omnibus database (GSE10950). The microarray hybridization of 24 colon normal and tumor pairs was performed using the Illumina Gene Expression Sentrix®BeadChip HumanRef-8_V2 and the expression data was normalized by cubic spline normalization in GeneSpring 7.2. Pair wise t-tests were used to detect differential expression between tumor and normal tissues. 
Results
Colon tumorigenesis in inbred strains
Two hundred sixty-eight male mice from 33 inbred mouse strains were measured for colon tumor multiplicity and volume 24 weeks after injection with AOM. In each of the strains examined, the tumors were localized exclusively within the distal colon and not detected grossly or histologically within the proximal colon. Inbred mouse strains had a large variability in AOMinduced colon tumor multiplicity and volume (Fig. 1) . Mean colon tumor multiplicity ranged from 0 to 38.6 (mean ± SD, 6.5 ± 8.6) and tumor volume ranged from 0 to 706.5 mm 
Genome-wide association analysis
To identify the genetic basis of colon tumorigenesis in the AOM model, we performed a genome wide association analysis on 33 strains of inbred mice using colon tumor multiplicity and volume as the phenotypes (Fig. 2) . To correct for population structure and genetic relatedness in inbred mouse strains (18), we used the EMMA approach to assess association of colon tumor susceptibility with SNPs. The distribution of observed P values was similar to the expected distribution, indicating no inflation of test statistics from population structure or any other form of bias (Supplementary fig. S2 ). Therefore, any bias due to population structure and genetic relatedness among inbred strains has been largely eliminated by the EMMA approach.
Using the permutation analysis, we established genome-wide significance levels of 0.05 and 0.10, which corresponds to a point-wise P value of 3.39 × 10 for tumor volume (Fig. 2) .
The GWAS identified 20 SNPs (P < 10 , respectively). These two SNPs achieved genome-wide significance level of 0.10.
Candidate genes nearby these two SNPs include Tas2r119, Snord123 and Sema5a (Fig. 3) . This is a novel susceptibility locus on the proximal mouse chromosome 15 and has not been reported in previous linkage studies (26) . (Supplementary fig. S3 ) (26) . Here, we systematically investigated genetic association signals in these colon tumor susceptibility loci. We first identified microsatellite markers flanking one LOD supporting interval in each susceptibility locus based on previous linkage mapping studies, and thus determined genomic locations of these loci. Using permutation analysis, we then established region-wide thresholds for declaring significant associations in each locus ( Table S1 ). The region-wide association analysis identified a number of SNPs showing significant associations with colon tumor susceptibility in five of 16 susceptibility loci, including susceptibility to colon cancer locus 3 (Scc3), Scc2, Scc12, Scc8 and colon-cancer susceptibility locus 1 (Ccs1) (Supplementary fig. S4 ). These linkage regions were generally refined into less than 1-Mb genomic regions by association mapping. They are located on chromosomes 1, 2, 7, 8 and 12, respectively.
Due to high linkage disequilibrium within the mouse genome, we also checked candidate genes in 500 kb flanking regions on either side of these susceptibility loci (Fig. 4) . Candidate genes in these refined linkage regions were prioritized based on location of the most significant SNPs, mRNA expression in tumors, and their functional relevance in the literature. The most significant association in the Scc3 was located at 176.7 Mb on chromosome 1 (rs32121685, P = 3.47 × 10 -4 ) ( Table 2 ). The refined Scc3 locus includes ten annotated genes, of which Fmn2 and Grem2 are major candidates. The Scc2 locus on chromosome 2 (rs28039498, P = 2.09 × 10 ). Eight candidate genes were identified in this locus: Gm2417, Galc, Gpr65, Kcnk10, Spata7, Ptpn21, Zc3h14, Zc3h14 and Eml5.
Gene expression of candidates in the identified loci
To identify if candidate genes were significantly activated or repressed in colon tumorigenesis, we analyzed gene expression profiles of colon tumors from Apc Min/+ (24) and AOM-induced (23) mouse colon tumor models compared to normal colon. Ten candidate genes had significant differential expression in both models of colon tumorigenesis compared to normal colon controls (P < 0.05) ( Table S2) . Sema5a, Grem2 and Rabep2 were the most significantly decreased transcripts in both Apc Min/+ and AOM mouse models; while Eif3c and Tufm were the most increased transcripts (Fig. 5) . When comparing human colon tumors with matched normal tissues, GREM2, SEMA5A and TUFM were altered in the consistent trends with the above mouse models (Table S2) .
Discussion
In the present study, we performed large-scale phenotyping to systematically evaluate the sensitivity of 33 inbred mouse strains to AOM-induced colon carcinogenesis (Fig. 1) . The strains used in the study were derived from genetically diverse genealogies and most of them are on the tumors in rodents (27) . In inbred mice, the high frequency of AOM-induced tumors was observed exclusively within the distal colon; the majority of mouse colon tumors arise as aberrant crypt foci, progress to adenomas, and ultimately result in adenocarcinomas, paralleling the progression of CRC in humans (27) . Notably, a recent study showed that APC protein is aberrant in AOM-induced mouse colon adenomas and carcinomas (28) . These support the use of mouse models for studying the genetics and pathogenesis of colon cancer. In general, AOMinduced colon cancer in rodents can recapitulate in a highly reliable way the phases of initiation and progression of tumor that occur in humans. However, it should be noted that p53 mutations are rarely observed and the tendency to metastasize is low in AOM-induced colon cancer mouse model (29). Other mouse models such as genetically modified animals are also very useful for studying diverse human CRC Using these AOM-induced colon tumor data, we performed a genome-wide association analysis in 268 mice from 33 inbred strains, and subsequently fine mapping of 16 previous linkage regions using the association data. The GWAS also identified a novel susceptibility locus on chromosome 15 in which Sema5a is a major candidate (Fig. 3) . Sema5a belongs to a large family of proteins involved in the patterning of both the vascular and the nervous systems.
Interestingly, Sema5a expression was significantly repressed in both Apc Min/+ and AOMinduced colon tumors (Fig. 5) .Fine mapping association analysis narrowed 5 of 16 QTLs for colon tumorigenesis into less than 1-Mb genomic regions of interest. This makes positional identification of candidate genes in these susceptibility loci more feasible (Fig. 4 and Table 2 ). 
two genes, Fmn2 and Grem2. Grem2 mRNA expression was significantly repressed in both
Apc
Min/+ and AOM-induced colon tumors, while we did not observed significant changes in Fmn2 expression. A recent GWAS identified common genetic variants at CRAC1 (HMPS) locus on human chromosome 15q13.3 that confers CRC risk in the Ashkenazi population (9) . The CRAC1 locus was initially characterized in the classical linkage analysis of families with hereditary mixed polyposis syndrome (HMPS). The HMPS is a Mendelian condition characterized by multiple colorectal polyps and CRC (30) . Interestingly, two candidate genes near the strongest SNP association were FMN1 and GREM1. Syntenic regions containing FMN1/GREM1 and FMN2/GREM2 are highly conserved between mice and humans. This has been suggested to arise from an ancient gene duplication event (Supplementary fig. S5 ) (31) .
Genes around the Scc3 locus in mice are present in the same order and orientation in humans.
These data suggest FMN1/GREM1 and FMN2/GREM2 may be lineage-specific susceptibility genes for colon cancer.
Three major candidates were identified in the refined Scc2 locus: Fap, Ifih1, and Gca.
Fap encodes a homodimeric integral membrane gelatinase belonging to the serine protease family. It is selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas (32, 33) . This gene is involved in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis. Abrogation of Fap enzymatic activity attenuates tumor growth in HEK293 cells (34) . Increased expression of Fap is associated with lymph node metastasis in colorectal, esophageal, ovarian and pancreatic cancers (35) (36) (37) (38) .
The refined Scc12 locus is a gene-rich region in which Gsg1l, Spns1, Rabep2, and Sh2b1 are interesting candidates. Of them, Spns1 play roles in programmed cell death in Drosophila 
14 melanogaster and has orthologs in nematode, mouse, and human (39) . Rabep2 is a RAB GTPase binding effector protein which encodes a member of AP-1 family of transcription factors involved in cell proliferation, differentiation, apoptosis, and other biological processes. Rebep2 was up-regulated in hyperplastic and neoplastic breast disorders (40) . Sh2b1mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular.
A recent study found that SH2-B beta specifically activates JAK2 and functions as an adapter protein that cross-links actin filaments, leading to modulation of cellular responses in response to JAK2 activation (41, 42) . Another study demonstrates an essential role of SH2-B beta in the activation of the Src kinase and the resulting mitogenic response, causing phenotypic cell transformation involving the Src substrate STAT3 (43) . The refined Scc8 locus only contained one predicted gene Gm3920 and one known gene Unc5d (i.e., Unc5h4). UNC5H4 is a netrin-1 receptor UNC5H family member and is a direct transcriptional target of p53 that is induced during DNA damage-mediated apoptosis (44) .
Gpr65, Ptpn21 and Eml5 are major candidates in the refined Ccs1 locus. Gpr65 encodes a pro-apoptotic G protein-coupled receptor that promotes glucocorticoid-induced apoptosis.
Activation of Gpr65 by its agonist psychosine markedly enhanced dexamethasone-induced apoptosis in a Gpr65-dependent manner (45) . Up-regulation of Gpr65 in human tumors is involved in driving or maintaining tumor formation (46) . Ptpn21 is a member of the protein tyrosine phosphatase (PTP) family that are known to regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. 
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In summary, we identified a novel susceptibility locus on mouse chromosome 15 for AOM-induced colon tumorigenesis through a genome-wide association study in inbred mice.
Subsequent fine mapping analysis further identified five of 16 previous linkage regions to be associated with colon tumor susceptibility. These susceptibility loci were narrowed to less than 1-Mb regions of interest in which candidate genes were identified. These findings will provide important insights into the pathways of CRC development and may ultimately lead to more effective individually targeted cancer-prevention strategies. 
